Belgian national burden of disease study 2020 | Preliminary results and moving forward

What are the most important diseases in Belgium? Which risk factors contribute most to the overall disease burden? How is the burden of disease evolving over time?

In a context of increasing budgetary constraints, a precise answer to these basic questions is more than ever necessary to inform policy-making. However, although various data sources routinely generate information on the Belgian health status, coherent and comparable estimates of the burden of diseases, injuries and risk factors in Belgium are lacking.

To address this gap, Sciensano initiated in 2016 a national burden of disease study. In addition to generating estimates of mortality and morbidity by age, sex and region, the burden of disease is also quantified using Disability-Adjusted Life Years (DALYs). The use of DALY allows to combine in a single indicator years of life lost from premature death and years of life lived with disabilities. It therefore permits a truly comparative ranking of the burden of various diseases, injuries and risk factors.

Attend this meeting and you will receive the preliminary results of the BeBOD2020 project. It also gives you the opportunity to discuss the way forward with the other participants.

Program

14h00 Welcome | Prof Dr Herman Van Oyen (Sciensano)
14h15 BeBOD2020: motivation, outline, and preliminary results | Prof Dr Brecht Devleesschauwer (Sciensano)
15h00 BeBOD2020: the way forward | group discussion
16h00 Conclusions and closure | Prof Dr Herman Van Oyen (Sciensano)

Registration

Please register before 12/10/2018.